270 related articles for article (PubMed ID: 35215916)
1. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
[TBL] [Abstract][Full Text] [Related]
2. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
[TBL] [Abstract][Full Text] [Related]
3. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
[TBL] [Abstract][Full Text] [Related]
5. Waning of SARS-CoV-2 booster viral-load reduction effectiveness.
Levine-Tiefenbrun M; Yelin I; Alapi H; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R
Nat Commun; 2022 Mar; 13(1):1237. PubMed ID: 35246560
[TBL] [Abstract][Full Text] [Related]
6. Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status.
Boschi C; Aherfi S; Houhamdi L; Colson P; Raoult D; Scola B
Emerg Microbes Infect; 2021 Dec; 10(1):2276-2278. PubMed ID: 34792434
[TBL] [Abstract][Full Text] [Related]
7. Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.
Mwendwa F; Kanji A; Bukhari AR; Khan U; Sadiqa A; Mushtaq Z; Nasir N; Mahmood SF; Aamir UB; Hasan Z
J Infect Public Health; 2024 Jun; 17(6):1100-1107. PubMed ID: 38714122
[TBL] [Abstract][Full Text] [Related]
8. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
Plante JA; Machado RRG; Mitchell BM; Shinde DP; Walker J; Scharton D; McConnell A; Saada N; Liu J; Khan B; Campos RK; Johnson BA; Menachery VD; Levine CB; Ren P; McLellan SLF; Plante KS; Weaver SC
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146877
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2.
Kumar N; Quadri S; AlAwadhi AI; AlQahtani M
Front Immunol; 2022; 13():812606. PubMed ID: 35237265
[TBL] [Abstract][Full Text] [Related]
11. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Fisher LH; Kee JJ; Liu A; Espinosa CM; Randhawa AK; Ludwig J; Magaret CA; Robinson ST; Gilbert PB; Hyrien O; Kublin JG; Rouphael N; Falsey AR; Sobieszczyk ME; El Sahly HM; Grinsztejn B; Gray GE; Kotloff KL; Gay CL; Leav B; Hirsch I; Struyf F; Dunkle LM; Neuzil KM; Corey L; Huang Y; Goepfert PA; Walsh SR; Baden LR; Janes H;
JAMA Netw Open; 2024 May; 7(5):e2412835. PubMed ID: 38780941
[TBL] [Abstract][Full Text] [Related]
13. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
Lee BU
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
Mastrorosa I; Cozzi-Lepri A; Colavita F; Lalle E; Mazzotta V; Cimaglia C; Paulicelli J; Matusali G; Fabeni L; Carletti F; Rosati S; Vita S; Giannico G; Piselli P; Biliotti E; Moghazi SA; Mosti S; Girardi E; Nicastri E; Garbuglia AR; Maggi F; Vaia F; Antinori A
J Clin Virol; 2022 Dec; 157():105299. PubMed ID: 36183546
[TBL] [Abstract][Full Text] [Related]
15. CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant.
Fumagalli MJ; Castro-Jorge LA; de Souza WM; de Azevedo PO; Hansen AW; Gazzinelli RT; da Fonseca BAL; Spilki FR; Figueiredo LTM
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215895
[TBL] [Abstract][Full Text] [Related]
16. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
[TBL] [Abstract][Full Text] [Related]
19. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.
Levine-Tiefenbrun M; Yelin I; Alapi H; Katz R; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R
Nat Med; 2021 Dec; 27(12):2108-2110. PubMed ID: 34728830
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
